| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +100.00% | -8.99% | +1.16% | -10.14% | -10.14% | — |
| 14d | 5 | +100.00% | -25.56% | — | — | — | — |
| 30d | 5 | +100.00% | -35.99% | +3.18% | -39.17% | -39.17% | — |
| 60d | 5(5 pending) | — | — | — | — | — | — |
| 90d | 5(5 pending) | — | — | — | — | — | — |
| 180d | 5(5 pending) | — | — | — | — | — | — |
| 1y | 5(5 pending) | — | — | — | — | — | — |
| 2y | 5(5 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AVTX AVALO THERAPEUTICS, INC. | SALE Chief Legal Officer | 1,081 | $13.10 | $14.2K | 32,576 | Jun 10, 2026 | Jun 12, 2026 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 24,300 | — | — | 27,934 | May 21, 2026 | May 26, 2026 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 9,253 | $22.70 | $210.0K | 4,034 | May 6, 2026 | May 7, 2026 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 37,375 | $18.91 | $706.8K | 41,322 | May 6, 2026 | May 7, 2026 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | SALE Chief Legal Officer | 12,563 | — | — | 87,437 | May 6, 2026 | May 7, 2026 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | PURCHASE Chief Legal Officer | 12,563 | $8.04 | $101.0K | 78,697 | May 6, 2026 | May 7, 2026 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 400 | $23.71 | $9.5K | 3,634 | May 6, 2026 | May 7, 2026 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 22,839 | $21.22 | $484.5K | 13,287 | May 6, 2026 | May 7, 2026 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | PURCHASE Chief Legal Officer | 62,500 | $13.43 | $839.4K | 66,134 | May 6, 2026 | May 7, 2026 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | SALE Chief Legal Officer | 62,500 | — | — | 87,500 | May 6, 2026 | May 7, 2026 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,196 | $19.78 | $102.8K | 36,126 | May 6, 2026 | May 7, 2026 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Feb 26, 2026 | Mar 2, 2026 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | SALE Chief Legal Officer | 1,016 | $4.10 | $4.2K | 3,634 | Dec 10, 2025 | Dec 12, 2025 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 28, 2025 | Jan 30, 2025 ↗ | View → |
| AVTX AVALO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Jun 24, 2024 | Jun 25, 2024 ↗ | View → |